首页> 外国专利> BENZOXAZINONES AND PHARMACEUTICAL COMPOSITION COMPRISING THEREOF FOR INHIBITION OF ACTIVITY OF HIV REVERSE TRANSCRIPTASE, TREATMENT AND PROPHYLAXIS OF AIDS AND ARS, METHOD OF INHIBITION OF ACTIVITY OF HIV REVERSE TRANSCRIPTASE, METHOD OF PROPHYLAXIS OF HIV INFECTION, TREATMENT OF HIV AND ARS, COMBINATIONS, METHOD OF SYNTHESIS OF (-)-6-CHLORO- -4-CYCLOPROPYLETHYNYL-4-TRIFLUOROMETHYL-1,4- -DIHYDRO-2H-3,1-BENZOXAZINE-2-ONE

BENZOXAZINONES AND PHARMACEUTICAL COMPOSITION COMPRISING THEREOF FOR INHIBITION OF ACTIVITY OF HIV REVERSE TRANSCRIPTASE, TREATMENT AND PROPHYLAXIS OF AIDS AND ARS, METHOD OF INHIBITION OF ACTIVITY OF HIV REVERSE TRANSCRIPTASE, METHOD OF PROPHYLAXIS OF HIV INFECTION, TREATMENT OF HIV AND ARS, COMBINATIONS, METHOD OF SYNTHESIS OF (-)-6-CHLORO- -4-CYCLOPROPYLETHYNYL-4-TRIFLUOROMETHYL-1,4- -DIHYDRO-2H-3,1-BENZOXAZINE-2-ONE

机译:苯甲恶嗪类及其组成,包括抑制HIV逆转录酶活性,艾滋病和ARS的治疗和预防,抑制HIV逆转录酶活性的方法,预防HIV感染的方法,HIV感染的预防方法,治疗方法(-)-6-氯--4-环丙基乙炔基-4-三氟甲基-1,4--二氢-2H-3,1-苯并恶嗪-2-一的合成

摘要

FIELD: organic chemistry, biochemistry, medicine, pharmacy. SUBSTANCE: invention describes novel benzoxazinone compounds of the general formula (I) where X means halogen atom; X1 means trihalogenmethyl; Z means O; R means: (a) unsubstituted C1-8-alkyl or that substituted with halogen atom, 5-membered saturated monocyclic ring comprising 1-2 heteroatoms taken among nitrogen and oxygen atoms; (b) unsubstituted C2-4-alkenyl or that substituted with C1-4-alkoxy-group; or (c) unsubstituted C2-5-alkynyl or that substituted with C3-6-cycloalkyl, hydroxy-group, di-(C1-2-alkyl)-amino-group, C1-4-alkoxy-group, unsubstituted phenyl of phenyl substituted with C1-4-alkoxy-group, nitro-group, CN, 5-membered saturated monocyclic ring comprising 1-2 heteroatoms taken among nitrogen and oxygen atoms, or its pharmaceutically acceptable salt. Compounds of the formula (I) can be used in aims for inhibition of activity of HIV reverse transcriptase (including its resistant forms) and also for aims of prophylaxis and treatment of HIV-infections and AIDS. The indicated compounds can be used both as such and as their pharmaceutically acceptable salts or as components of pharmaceutical compositions used both separately and in combination with other antiviral agents, immunomodulating agents, antibiotics or vaccines. Invention discloses also methods of treatment of AIDS, prophylaxis and treatment of HIV-infections and method of synthesis of (-)-6-chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4- -dihydro-2H-3,1-benzoxazine-2-one. EFFECT: improved method of synthesis, valuable medicinal properties. 13 cl, 5 tbl, 6 ex
机译:领域:有机化学,生物化学,医学,药学。物质:本发明描述了通式(I)的新型苯并恶嗪酮化合物。<图像文件=“ 00000002.GIF” he =“ 26” imgContent =“ undefined” imgFormat =“ GIF” wi =“ 39” />其中X表示卤素原子; X 1 表示三卤代甲基; Z表示O; R是指:(a)未取代的C 1-8 -烷基或被卤素原子取代的,含1-2个氮原子和氧原子的5元饱和单环; (b)未取代的C 2-4 -烯基或被C 1-4 -烷氧基取代的基团;或(c)未取代的C 2-5 -炔基或被C 3-6 -环烷基,羟基,二-(C 1-2 -烷基)-氨基,C 1-4 -烷氧基,被C 1-4 -烷氧基取代的苯基的未取代苯基,含氮和氧原子中的1-2个杂原子的硝基,CN,5元饱和单环或其药学上可接受的盐。式(I)化合物可用于抑制HIV逆转录酶活性(包括其抗性形式)的目的,也可用于预防和治疗HIV感染和AIDS的目的。所指示的化合物既可以本身使用,也可以以其药学上可接受的盐的形式使用,也可以单独或与其他抗病毒剂,免疫调节剂,抗生素或疫苗组合使用。本发明还公开了治疗艾滋病的方法,预防和治疗HIV感染以及合成(-)-6-氯-4-环丙基乙炔基-4-三氟甲基-1,4--二氢-2H-3,1-的方法苯并恶嗪-2-酮。功效:改良的合成方法,有价值的药用特性。 13 cl,5 tbl,6前

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号